Malin Corporation | MLC - Assets


Malin Corporation reported EUR198.5M in Assets for its fiscal semester ending in December of 2024.





Assets Change Date
Akebia Therapeutics USD 349.66M 12.86M Jun/2026
Alaunos Therapeutics USD 1.88M 1.08M Mar/2026
ALKERMES USD 4.39B 135.05M Jun/2026
Avita Medical AUD 56.39M 1.74M Dec/2025
Dianthus Therapeutics USD 1.21B 33.61M Jun/2026
Eurofins Scientific SE EUR 11.11B 123M Jun/2026
Ionis Pharmaceuticals USD 2.99B 455.5M Jun/2026
IQVIA Holdings USD 29.88B 206M Jun/2026
Lonza CHF 18.97B 164M Dec/2025
Malin Corporation EUR 198.5M 70.1M Dec/2024
Moderna USD 10.96B 527M Jun/2026
Organon & Co USD 13.18B 182M Jun/2026
Ovoca Bio EUR 2.07M 414K Dec/2025
Revvity USD 12.05B 49.24M Jun/2026
Tectonic Therapeutic USD 246.58M 14.46M Mar/2026
Viatris USD 35.04B 1.79B Jun/2026
Xeris Pharmaceuticals USD 411.9M 19.89M Jun/2026